These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 11070351)
1. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors. Billich A; Nussbaumer P; Lehr P J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351 [TBL] [Abstract][Full Text] [Related]
2. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase. Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells. Selcer KW; Kabler H; Sarap J; Xiao Z; Li PK Steroids; 2002 Sep; 67(10):821-6. PubMed ID: 12231117 [TBL] [Abstract][Full Text] [Related]
4. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor. Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate. Purohit A; Williams GJ; Howarth NM; Potter BV; Reed MJ Biochemistry; 1995 Sep; 34(36):11508-14. PubMed ID: 7547880 [TBL] [Abstract][Full Text] [Related]
6. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models. Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815 [TBL] [Abstract][Full Text] [Related]
7. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells. MacIndoe JH Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800 [TBL] [Abstract][Full Text] [Related]
8. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates. Woo LL; Purohit A; Malini B; Reed MJ; Potter BV Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081 [TBL] [Abstract][Full Text] [Related]
9. Sulfamoyloxy-substituted 2-phenylindoles: antiestrogen-based inhibitors of the steroid sulfatase in human breast cancer cells. Golob T; Liebl R; von Angerer E Bioorg Med Chem; 2002 Dec; 10(12):3941-53. PubMed ID: 12413846 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives. Selcer KW; Jagannathan S; Rhodes ME; Li PK J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo models for the evaluation of new inhibitors of human steroid sulfatase, devoid of residual estrogenic activity. Shields-Botella J; Bonnet P; Duc I; Duranti E; Meschi S; Cardinali S; Prouheze P; Chaigneau AM; Duranti V; Gribaudo S; Rivière A; Mengual L; Carniato D; Cecchet L; Lafay J; Rondot B; Sandri J; Pascal JC; Delansorne R J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):327-35. PubMed ID: 12711019 [TBL] [Abstract][Full Text] [Related]
12. Development of potent non-estrogenic estrone sulfatase inhibitors. Li PK; Chu GH; Guo JP; Peters A; Selcer KW Steroids; 1998; 63(7-8):425-32. PubMed ID: 9654650 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene. Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965 [TBL] [Abstract][Full Text] [Related]
15. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats. Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348 [TBL] [Abstract][Full Text] [Related]
16. Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential. Thomas MP; Potter BV J Steroid Biochem Mol Biol; 2015 Sep; 153():160-9. PubMed ID: 25843211 [TBL] [Abstract][Full Text] [Related]
17. Reversal of scopolamine induced amnesia in rats by the steroid sulfatase inhibitor estrone-3-O-sulfamate. Li PK; Rhodes ME; Jagannathan S; Johnson DA Brain Res Cogn Brain Res; 1995 Oct; 2(4):251-4. PubMed ID: 8580738 [TBL] [Abstract][Full Text] [Related]
18. Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. Nakata T; Takashima S; Shiotsu Y; Murakata C; Ishida H; Akinaga S; Li PK; Sasano H; Suzuki T; Saeki T J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):455-60. PubMed ID: 14623544 [TBL] [Abstract][Full Text] [Related]
19. Peripheral steroid sulfatase inhibition potentiates improvement of memory retention for hippocampally administered dehydroepiandrosterone sulfate but not pregnenolone sulfate. Flood JF; Farr SA; Johnson DA; Li PK; Morley JE Psychoneuroendocrinology; 1999 Nov; 24(8):799-811. PubMed ID: 10581651 [TBL] [Abstract][Full Text] [Related]
20. Constitutive expression of the steroid sulfatase gene supports the growth of MCF-7 human breast cancer cells in vitro and in vivo. James MR; Skaar TC; Lee RY; MacPherson A; Zwiebel JA; Ahluwalia BS; Ampy F; Clarke R Endocrinology; 2001 Apr; 142(4):1497-505. PubMed ID: 11250930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]